Defining high, medium and low impact prognostic factors for developing multiple sclerosisMar Tintoré, Xavier Montalbán, Cristina Auger et al.|Brain|2015Cited by 520
Factors related with treatment adherence to interferon b and glatiramer acetate therapy in multiple sclerosisJordi Río, Xavier Montalbán, J. Porcel et al.|Multiple Sclerosis Journal|2005Cited by 188
Spinal cord lesions: A modest contributor to diagnosis in clinically isolated syndromes but a relevant prognostic factorGeorgina Arrambide, Mar Tintoré, Àlex Rovira et al.|Multiple Sclerosis Journal|2017Cited by 117
A functional magnetic resonance proof of concept pilot trial of cognitive rehabilitation in multiple sclerosisJaume Sastre‐Garriga, Àlex Rovira, Juli Alonso et al.|Multiple Sclerosis Journal|2010Cited by 109
Neurofilament light chain level is a weak risk factor for the development of MSGeorgina Arrambide, Mar Tintoré, Carmen Espejo et al.|Neurology|2016Cited by 108